Found 64 matching trials
Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer PHASE2 This phase II trial studies how well docetaxel or abiraterone acetate work ...
Show More Location
Huntsman Cancer Institute/University of Utah
Learn More & Join Trial
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer PHASE3 This randomized phase III trial studies enzalutamide to see how well it wor...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer PHASE3 This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Show More Location
The Mayo Clinic - Phoenix
Learn More & Join Trial
Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer PHASE2 This phase II trial studies how well apalutamide and gonadotropin-releasing...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
PET/CT Characterization of Treatment Resistance NA This study will use different types of medical imaging to assess how lesion...
Show More Location
University of Wisconsin
Learn More & Join Trial
Phase 1 of EC1169 In Patients With Recurrent MCRPC PHASE1 The purpose of this study is to determine the safety of EC1169 and the best...
Show More Location
Scottsdale Healthcare Clinical Trials at the Virginia G. Piper Cancer Center
Learn More & Join Trial
A Study to Assess the Effect of Timing of Food Intake on the Pharmacokinetics of Abiraterone Following Single-Dose Administration of Abiraterone Acetate Tablets in Healthy Caucasian and Japanese Men PHASE1 The purpose of this study is to evaluate the effect of timing of food intak...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment PHASE3 The purpose of this study is to evaluate the efficacy and safety of \[Lu-17...
Show More Status
Active Not Recruiting
Location
Arizona Institute of Urology (AIU) - Tucson
Learn More & Join Trial
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone PHASE2 This Phase II study has been designed to evaluate the anti-tumor effects of...
Show More Location
Prostate Oncology Specialists, Inc.
Learn More & Join Trial
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) PHASE2 Single-arm, single site, open label study of the effects of parenteral test...
Show More Location
Sibley Memorial Hospital
Learn More & Join Trial